
Injective Jumps 68.6% in a Month on Washington Meetings and ETF Filings
- —INJ at $9.03: up 14.5% daily and 68.6% monthly, market cap around $903 million
- —Injective CEO Eric Chen met White House, SEC and CFTC officials on October 15
- —Injective Institutional Services registered as an SEC transfer agent
- —21Shares filed for spot ETF TINJ; Canary's staking ETF INJS plans at least 90% of INJ staked
Why it matters: The rally rests on a regulatory narrative rather than revenue: protocol income is only about $3.58 million a year, so ETF approval will be the key test of real demand.
Source: 動區 BlockTempo